Learn More About Christina Åkerman
The global health care industry faces a glaring contradiction: rising costs that do not amount to better quality care. The Value-Based Health Care movement seeks to address this problem by changing what we measure – from processes to the outcomes that matter the most to the patient. But which metrics amount to successful measurement of value in health care? Dr. Christina Åkerman, M.D. is the world’s leading expert on developing a common global set of measurements for determining the success of care. Dr. Åkerman’s metrics help organizations throughout the world, from hospitals to insurance and pharmaceutical companies, measure value in a universal language – and transform health care as we know it.
Senior institute associate at the Institute for Strategy and Competitiveness (ISC) at Harvard Business School, Dr. Åkerman focuses on devising a global methodology that can drive improvements in patient well-being while overcoming barriers to convergence on best practices. In addition to her work on harmonizing global standards, Dr. Åkerman shows health care organizations how they can improve quality through cross-functional collaboration to treat patients holistically. She also equips medical educators with a new framework for integrating outcomes-based measurement into clinician training, enabling future providers to move away from an overly process-based approach.
Now chair of the 5612 Group AB, Dr. Åkerman was formerly president of the International Consortium for Health Outcomes Measurement (ICHOM), a non-profit organization with the goal to transform health care systems worldwide by measuring and reporting patient outcomes in a standardized way. She previously served as director general for the Medical Products Agency (MPA) in Sweden, a national agency under the aegis of the Swedish Ministry of Health and Social Affairs. During this period, she was also a member of the Board of the European Medicines Agency (EMA), which is responsible for the scientific evaluation of medicines for use in the European Union.
Before her position with MPA, Dr. Åkerman served as vice president medical of AstraZeneca Sweden as well as marketing company president of AstraZeneca Philippines. She has also been working chair of start-up companies and on the board of Fouriertransform, a Swedish state-owned venture capital company.
Dr. Åkerman received her medical degree from the University of Linköping. She wrote her doctoral thesis in Clinical Physiology and is a specialist in Clinical Pharmacology. She has an Executive MBA in General Management from the Stockholm School of Economics.
Christina Åkerman is available to advise your organization via virtual and in-person consulting meetings, interactive workshops and customized keynotes through the exclusive representation of Stern Speakers & Advisors, a division of Stern Strategy Group®.